Head to Head Analysis: Heart Test Laboratories (NASDAQ:HSCS) & Anteris Technologies Global (NASDAQ:AVR)

Heart Test Laboratories (NASDAQ:HSCS) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Heart Test Laboratories and Anteris Technologies Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	-117.76%	-84.09%
Anteris Technologies Global	N/A	N/A	N/A

Valuation and Earnings

This table compares Heart Test Laboratories and Anteris Technologies Global”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$14,700.00	246.00	-$6.61 million	($7.91)	-0.47
Anteris Technologies Global	$2.71 million	109.37	N/A	N/A	N/A

Anteris Technologies Global has higher revenue and earnings than Heart Test Laboratories.

Analyst Recommendations

This is a summary of current ratings and price targets for Heart Test Laboratories and Anteris Technologies Global, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0	0	2	0	3.00
Anteris Technologies Global	0	0	4	0	3.00

Heart Test Laboratories presently has a consensus price target of $13.50, indicating a potential upside of 265.85%. Anteris Technologies Global has a consensus price target of $16.50, indicating a potential upside of 100.00%. Given Heart Test Laboratories’ higher possible upside, analysts clearly believe Heart Test Laboratories is more favorable than Anteris Technologies Global.

Institutional and Insider Ownership

17.2% of Heart Test Laboratories shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.